Therapeutic implications of menin inhibition in acute leukemias
Por um escritor misterioso
Descrição
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors
Therapeutic implications of menin inhibition in acute leukemias
Challenges and opportunities in targeting the menin–MLL
Frontiers Targeted therapy in NPM1-mutated AML: Knowns and unknowns
Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and
Targeting the undruggable: menin inhibitors ante portas
Novel Therapies Targeting Menin for Relapsed or Refractory Acute
Hagop Kantarjian,MD on X: Menin inhibitors could be the next
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression
A molecular switch between mammalian MLL complexes dictates
.png?1670008838)
Ahead in menin inhibitor race, Syndax plans FDA filing in high
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors
